COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study

BACKGROUND: COVID-19 vaccine-induced antibody responses are reduced in patients with inflammatory bowel disease (IBD) taking anti-TNF or tofacitinib after two vaccine doses. We sought to assess whether immunosuppressive treatments were associated with reduced antibody and T-cell responses in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexander, James L, Liu, Zhigang, Muñoz Sandoval, Diana, Reynolds, Catherine, Ibraheim, Hajir, Anandabaskaran, Sulak, Saifuddin, Aamir, Castro Seoane, Rocio, Anand, Nikhil, Nice, Rachel, Bewshea, Claire, D'Mello, Andrea, Constable, Laura, Jones, Gareth R, Balarajah, Sharmili, Fiorentino, Francesca, Sebastian, Shaji, Irving, Peter M, Hicks, Lucy C, Williams, Horace R T, Kent, Alexandra J, Linger, Rachel, Parkes, Miles, Kok, Klaartje, Patel, Kamal V, Teare, Julian P, Altmann, Daniel M, Goodhand, James R, Hart, Ailsa L, Lees, Charlie W, Boyton, Rosemary J, Kennedy, Nicholas A, Ahmad, Tariq, Powell, Nick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458592/
https://www.ncbi.nlm.nih.gov/pubmed/36088954
http://dx.doi.org/10.1016/S2468-1253(22)00274-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458592/
https://www.ncbi.nlm.nih.gov/pubmed/36088954
http://dx.doi.org/10.1016/S2468-1253(22)00274-6

Ejemplares similares